Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
Open Access
- 3 July 2007
- journal article
- research article
- Published by Springer Nature in Molecular Imaging & Biology
- Vol. 9 (5) , 318-322
- https://doi.org/10.1007/s11307-007-0108-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Surgical mediastinal staging in daily practiceLung Cancer, 2005
- Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Positron emission tomography with 2-[18f]fluoro-2-deoxy-d-glucose: can it be used to accurately stage the mediastinum in non–small cell lung cancer as an alternative to mediastinoscopy?The Journal of Thoracic and Cardiovascular Surgery, 2003
- The value of [18F]fluoro-2-deoxy-?-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatmentLung Cancer, 2003
- Value of FDG-PET in the management of non-small cell lung cancerEuropean Journal of Radiology, 2003
- Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancerThorax, 2003
- Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trialThe Lancet, 2002
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- Radiology's Achilles' heel: error and variation in the interpretation of the Röntgen image.The British Journal of Radiology, 1997
- Regional Lymph Node Classification for Lung Cancer StagingChest, 1997